Aprotinin reduces the expression of p-selectin on the surface of platelet and leukocyte-platelet conjugates. 1998

K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
Second Department of Surgery, Yamagata University School of Medicine, Japan.

P-Selectin, an adhesion molecule expressed on the surfaces of activated platelets and the vascular endothelium, mediates platelet binding to monocytes and neutrophils. Monocytes and neutrophils produce superoxide anion by activated platelets through p-selectin. Aprotinin, a serine protease inhibitor, inhibits plasmin to activate platelets during cardiopulmonary bypass (CPB). A total of 25 patients were studied to clarify the effects of aprotinin on p-selectin expression during CPB. Nine patients were not given aprotinin (control group), and 16 were given aprotinin of 2 million U in the priming solution (aprotinin group). The platelet count and soluble p-selectin in the plasma, p-selectin on the surface membranes of platelets, and leukocyte-platelet conjugate levels were measured during and after CPB. The platelet count was maintained well in the aprotinin group. The increases of soluble p-selectin in the plasma, platelet surface p-selectin, and leukocyte-platelet conjugates were less in the aprotinin group than in the control group (p < 0.05). In conclusion, aprotinin in patients undergoing CPB may reduce the early inflammatory reactions induced by p-selectin.

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine
D019007 P-Selectin Cell adhesion molecule and CD antigen that mediates the adhesion of neutrophils and monocytes to activated platelets and endothelial cells. Antigens, CD62P,CD62P Antigens,GMP-140,LECAM-3,P Selectin,Platelet alpha-Granule Membrane Protein,CD62P Antigen,PADGEM,Antigen, CD62P,Platelet alpha Granule Membrane Protein,Selectin, P

Related Publications

K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
June 2009, Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists,
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
April 2018, Arteriosclerosis, thrombosis, and vascular biology,
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
March 2002, Clinical pharmacology and therapeutics,
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
January 2010, The American journal of emergency medicine,
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
April 2002, Biochemical and biophysical research communications,
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
August 2004, Journal of thrombosis and thrombolysis,
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
August 2013, Microcirculation (New York, N.Y. : 1994),
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
July 1999, Transfusion,
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
March 2003, Clinical pharmacology and therapeutics,
K Inui, and Y Shimazaki, and T Watanabe, and S Kuraoka, and K Uesho, and T Uchida, and S Shiono
October 2005, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!